# -*- coding: utf-8 -*-
#+TITLE: Multiple Carboxylase Deficiency
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+EMAIL: matthew@darwin.local
#+DATE: \today

:PROPERTIES:
#+DRAWERS: PROPERTIES
#+LaTeX_CLASS: beamer
#+LaTeX_CLASS_OPTIONS: [presentation, smaller]
# #+BEAMER_THEME: Ilmenau [height=20pt]
# #+BEAMER_THEME: Szeged  [height=20pt]
#+BEAMER_THEME: Boadilla [height=20pt]
#+BEAMER_COLOR_THEME: [RGB={170,160,80}]{structure}
#+BEAMER_FRAME_LEVEL: 2
#+COLUMNS: %40ITEM %10BEAMER_env(Env) %9BEAMER_envargs(Env Args) %4BEAMER_col(Col) %10BEAMER_extra(Extra)
#+OPTIONS: H:2 toc:t
#+STARTUP: beamer
#+STARTUP: overview
#+STARTUP: hidestars
#+STARTUP: indent
# #+BEAMER_HEADER: \subtitle{Document subtitle}
#+BEAMER_HEADER: \institute[NSO]{Newborn Screening Ontario}
#+BEAMER_HEADER: \titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
#+latex_header: \hypersetup{colorlinks,linkcolor=gray,urlcolor=blue}
#+LaTeX_header: \usepackage{textpos}
#+LaTeX_header: \usepackage{textgreek}
#+LaTeX_header: \usepackage[version=4]{mhchem}
#+LaTeX_header: \usepackage{chemfig}
#+LaTeX_header: \usepackage{siunitx}
#+LaTeX_header: \usepackage{gensymb}
#+LaTex_HEADER: \usepackage[usenames,dvipsnames]{xcolor}
#+LaTeX_HEADER: \usepackage[T1]{fontenc}
#+LaTeX_HEADER: \usepackage{lmodern}
#+LaTeX_HEADER: \usepackage{verbatim}
#+LaTeX_HEADER: \usepackage{tikz}
#+LaTeX_HEADER: \usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
#+LaTeX_HEADER: \AtBeginSection[]{\begin{frame}\tableofcontents[currentsection] \end{frame}}
:END:

#+BEGIN_LaTeX
\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}}

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}


\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=8em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{box} = [rectangle, rounded corners, text width=5em, minimum height=5em,text centered, draw=black, fill=none]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]


#+END_LaTeX

* Introduction

** Multiple Carboxylase Deficiency
- Four carboxylases:
  - pyruvate carboxylase
  - acetyl-CoA carboxylase
  - propionyl carboxylase
  - 3-methylcrotonyl carboxylase

** Carboxylases


[[./figures/carboxylases.png]]

** Causes of Multiple Carboxylase Deficiency
- Biotin Deficiency
- Holocarboxylase Synthetase Deficiency
- Biotinidase Deficiency

**  Holocarboxylase Synthetase 
- HCS activates biotin to D-biotin-5'-adenylate
- catalyzes attachment to an apocarboxylase
  - lysine \epsilon{}-amino group

[[./figures/hcs.png]]

** Holocarboxylase Synthetase Deficiency
- Increased Km for Biotin
  - Normally 1-6 nmol/L, patients 9-12 nmol/L

#+begin_src gnuplot :file ./figures/kinetics.png
  reset
  set title "HCS Kinetics"
  set xlabel "Substrate [S]"
  set xrange [0:100]
  set ylabel "Velocity (V)"
  set yrange [0:60]
  f(vmax,km,x) = (vmax*x)/(x + km)
  v(vmax,km,x) = vmax * x/(x + km) 
  vmax1 = 50 
  km1 = 15
  vmax2 = 48
  km2 = 42

  set arrow from 0,vmax1 to 100,vmax1 lw 2 nohead  lc 1
  set label 1 at 3,(vmax1 +1.5) "Vmax" front
  set arrow from 0,vmax2 to 100,vmax2 lw 2 nohead  lc 2
  set label 2 at (km1 + 0.5),7 "Km WT" front
  set label 3 at (km2 + 0.5),7 "Km MCD" front
  set arrow from km1,0 to km1,f(vmax1,km1,km1) lw 2 nohead
  set arrow from 0,v(vmax1,km1,km1) to km1,v(vmax1,km1,km1) lw 2 nohead
  set arrow from km2,0 to km2,f(vmax2,km2,km2) lw 2 nohead
  set arrow from 0,v(vmax2,km2,km2) to km2,v(vmax2,km2,km2) lw 2 nohead

  plot f(vmax1,km1,x) with lines lw 2 title 'WT',\
       f(vmax2,km2,x) with lines lw 2 title 'MCD'

#+end_src

#+BEGIN_center
#+ATTR_LATEX: :width 0.7\textwidth 
#+RESULTS:
[[file:./figures/kinetics.png]]
#+END_center
** Biotinidase

[[./figures/biot.png]]

** Biotin and HCS

[[./figures/biotHCS.png]]


** Treatment
- All symptoms and biochemical abnormalities treated with biotin.
  - Except optic and auditory nerve atrophy
  - Biocytin?

* COMMENT Laboratory Methods

** Biotinidase NBS

- DBS is eluted and incubated 

#+BEGIN_LaTeX
\centering
\ce{Biotin-PAB <=>>[Biotinidase][pH=6] Biotin + PABA}
#+END_LaTeX

- proteins removed by TCA precipitation and filtration.

#+BEGIN_LaTeX
\ce{PABA <=>>[\ce{NO2, NH2SO3}][NED] Purple chromophore}
#+END_LaTeX

- measured at 550 nm, reference 690 nm 
- Sulfonamide antibiotics can cause false negative results:
  - sulfamethoxazole, trimethoprim, sulfioxazole

*** Interpretation
- screen positive :: \lt 27.0 MRU
- units :: 1 MRU = 1 umol of PABA produced from Biotin-PAB  

** Biotinidase Diagnostic

- serum or plasma

#+BEGIN_LaTeX
\centering
\ce{Biotin-PAB <=>>[Biotinidase][pH=6] Biotin + PABA}
#+END_LaTeX

- proteins removed by TCA precipitation and centrifugation.

#+BEGIN_LaTeX
\ce{PABA <=>>[\ce{NaNO2, NH2SO3}][NED] Purple chromophore}
#+END_LaTeX

 - measured at 546 nm

*** Interpretation
- Deficiency :: \le 10% of normal
- Partial :: \gt 10% and \le 30%
- units :: nmoles/min/L plasma or serum.

** Other Biotinidase methods

*** Fluorometric
- flourescent substrate is biotinyl-6-aminoquinoline 
*** Solid phase time-resolved immunofluorescence
- Biotinidase cleaves the amide bond in Eu-labeled biotin.
- The enzyme reaction is stopped by addition of streptavidin.
- The streptavidin-biotin complexes are captured by the solid phase monoclonal antibody directed against streptavidin.
- dissociates the molecules into the solution where the europium fluorescence is measured.
- The measured fluorescence is inversely proportional to the biotinidase activity of the sample.

** COMMENT Biotin
*** Competitive ELISA
- The microtiter plates coated with avidin.
- The enzyme-labeled biotin (Conjugate) and the sample or the Biotin Standard Solution are added.
- Free and enzyme-labeled biotin compete for the avidin-binding sites.
- avidin binding is not specific for biotin

*** Bioassay
- The E. coli strain R901 (\Delta{}bio SmR) has its entire biotin operon
  deleted
- requires biotin (\ge 10 pg/ml) for growth
- linear relationship between CFU and biotin concentration

** HCS NBS

- C5OH acylcarnitine
- No longer include C5OH acylcarnitine in the NSO AACC screen
- 3-methylcrotonyl-CoA carboxylase (3MCC) deficiency (infant or mother)
- 3-hydroxy-3-methylglutaryl (HMG)-CoA lyase deficiency
- \beta{}-ketothiolase deficiency
- multiple carboxylase deficiency (MCD) including biotinidase deficiency and holocarboxylase synthetase deficiency
- 2-methyl-3-hydroxybutyric acidemia (2M3HBA)
- 3-methylglutaconic aciduria (3MGA)

** HCS Diagnostic

- Urine organic acids
  - \beta{}-hydroxyisovalerate
  - \beta{}-methylcrotonylglycine
  - \beta{}-hydroxypropionate
  - methylcitrate
  - lactate
  - tiglylglycine 




